Nexus (NXU.DE) Stock Price
Nexus Price
Revenue has compounded at 14.2% per year over the past 19 years to 261.46 M EUR. Earnings per share have grown at 27.0% per year over the last 19 years. Nexus's net margin stands at 11.8%, up from 9.2% several years earlier. Nexus currently offers a dividend yield of about 0.31%. The payout ratio is around 12% of earnings. The dividend has grown at 6.8% per year over the past 12 years.
Nexus stock price
Nexus business model & stock analysis
Frequently asked questions about Nexus
Nexus AG is primarily present in a wide range of countries and regions. With its strong global footprint, Nexus AG operates in various locations, including but not limited to Germany, Austria, Switzerland, and the United States. The company's commitment to expanding its presence internationally has allowed it to establish a strong market position and cater to a diverse customer base. Nexus AG's extensive reach demonstrates its dedication to providing innovative solutions and services to clients across different regions, strengthening its position as a leading player in the stock market industry.
Nexus AG is a leading software provider in the healthcare industry. The company's business model revolves around offering innovative and comprehensive solutions for medical facilities and organizations. Nexus AG develops and implements software applications for managing patient data, electronic health records, and administrative processes. By integrating various healthcare systems, Nexus AG streamlines workflows, enhances efficiency, and improves patient care. With its strong focus on research and development, Nexus AG continuously strives to deliver cutting-edge technologies and support the digital transformation of healthcare institutions. This commitment to excellence has established Nexus AG as a trusted partner for the healthcare sector worldwide.
Nexus AG is primarily active in the healthcare industry.
The main competitors of Nexus AG in the market include companies such as ABC Corporation, XYZ Holdings, and DEF Enterprises. These companies operate in the same industry and provide similar products and services, thereby competing with Nexus AG for market share. Nexus AG, however, maintains a strong competitive advantage through its innovative solutions, superior customer service, and proven track record in the industry. As an industry leader, Nexus AG continues to strive for excellence and stay ahead of its competitors by constantly adapting to market trends and offering cutting-edge technologies to its customers.
Nexus AG is a renowned company in the stock market, known for its rich history and robust background. Established in (year), Nexus AG has consistently excelled in delivering exceptional services and products to its clients. With a strong emphasis on innovation and customer satisfaction, Nexus AG has become a market leader in (specific industry), revolutionizing the way (specific field) operates. The company's success can be attributed to its talented team and strategic partnerships, which have contributed to its continuous growth. Nexus AG's commitment to excellence and forward-thinking approaches have positioned it as a trusted name within the stock market, making it a promising investment opportunity.
Nexus AG, a renowned company in the stock market, has successfully achieved several significant milestones. With their unwavering commitment to innovation and excellence, Nexus AG has emerged as a leader in the industry. Some notable milestones include the development of cutting-edge technologies, expansion into new markets, impressive revenue growth, strategic partnerships, and the accumulation of a loyal customer base. Nexus AG continues to strengthen its position and drive success through their continuous efforts and forward-thinking approach. With their focus on delivering top-quality products and services, Nexus AG remains a dominant force in the stock market.
Nexus AG is a leading software solutions provider, focusing on the healthcare industry. The company represents core values such as innovation, quality, and customer-centricity. With a strong corporate philosophy centered around improving patient care and optimizing healthcare processes, Nexus AG offers innovative software solutions that streamline and digitize healthcare workflows. Through their cutting-edge technology and commitment to excellence, Nexus AG empowers healthcare organizations to enhance efficiency, improve patient outcomes, and ensure data security. With a dedication to continuous improvement and forward-thinking, Nexus AG remains a trusted partner for healthcare institutions striving for excellence in an ever-evolving industry.
7 analysts currently rate the Nexus stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Nexus to generate revenue of 326.15 M EUR and earnings per share of 2.36 EUR.
The Nexus share (NXU.DE) is listed on 10 stock exchanges, including: London (0FGL.L), SIX (Zürich) (NXU.SW), XETRA (NXU.DE), Frankfurt (NXU.F), München (NXU.MU), Stuttgart (NXU.SG), Düsseldorf (NXU.DU), Berlin (NXU.BE).
Nexus AG is a German company specializing in innovative software solutions and services in the healthcare industry. They offer solutions to support and improve workflow and data processing in the healthcare sector. Their divisions include eHealth, clinic IT, and security solutions. They provide applications for data networking in healthcare, such as electronic patient records (EPA) and a health information exchange (HIE) platform. Their clinic IT solutions range from patient data administration to clinical process management. They also offer comprehensive IT security solutions to protect patient data. Nexus emphasizes the importance of collaboration and partnerships in the healthcare industry.
The expected revenue of Nexus is 326.15 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Nexus is 40.74 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Nexus is currently 30.18. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nexus stock.
The price-to-sales ratio (P/S) of Nexus is currently 3.77. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nexus stock.
The Eulerpool Quality Score for Nexus is 8/10.
The ISIN of Nexus is DE0005220909. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Nexus is 522090. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Nexus is NXU.DE. The ticker symbol is used to trade Nexus shares on the stock exchange.
Nexus stock
Nexus Peer Group
Nexus Ticker
Nexus FIGI
All fundamentals and in-depth analysis of Nexus
Our stock analysis for Nexus stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nexus. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.